KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 74 filers reported holding KINNATE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $11,156 | -8.9% | 1,785 | -11.1% | 0.00% | 0.0% |
Q4 2022 | $12,249 | -44.7% | 2,008 | +8.4% | 0.00% | 0.0% |
Q3 2022 | $22,131 | -5.2% | 1,852 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $23,354 | +12.0% | 1,852 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $20,854 | -84.3% | 1,852 | -75.3% | 0.00% | -50.0% |
Q4 2021 | $133,077 | -23.0% | 7,510 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $172,880 | +18.2% | 7,510 | +60.0% | 0.00% | +50.0% |
Q1 2021 | $146,234 | – | 4,693 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|